Final NHS green light for Amgen’s Kyprolis
admin 20th July 2017 Uncategorised 0Patients living with multiple myeloma across England and Wales should now get ‘routine’ access to Amgen’s Kyprolis on the NHS within three months following a final green light from the National Institute for Health and Care Excellence.
More: Final NHS green light for Amgen’s Kyprolis
Source: News